Your browser doesn't support javascript.
loading
PSMA-PET- and MRI-Based Focal Dose Escalated Radiation Therapy of Primary Prostate Cancer: Planned Safety Analysis of a Nonrandomized 2-Armed Phase 2 Trial (ARO2020-01).
Zamboglou, Constantinos; Spohn, Simon K B; Ruf, Juri; Benndorf, Matthias; Gainey, Mark; Kamps, Marius; Jilg, Cordula; Gratzke, Christian; Adebahr, Sonja; Schmidtmayer-Zamboglou, Barbara; Mix, Michael; Bamberg, Fabian; Zschaeck, Sebastian; Ghadjar, Pirus; Baltas, Dimos; Grosu, Anca L.
Afiliación
  • Zamboglou C; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium, Partner Site, Freiburg, Germany; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Germany; German Oncology Center, European
  • Spohn SKB; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium, Partner Site, Freiburg, Germany; Berta-Ottenstein-Programme, Faculty of Medicine, University of Freiburg, Germany. Electronic address: simon.spohn@
  • Ruf J; German Cancer Consortium, Partner Site, Freiburg, Germany; Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Benndorf M; German Cancer Consortium, Partner Site, Freiburg, Germany; Department of Radiology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Gainey M; German Cancer Consortium, Partner Site, Freiburg, Germany; Division of Medical Physics, Department of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Kamps M; German Cancer Consortium, Partner Site, Freiburg, Germany; Department of Urology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Jilg C; German Cancer Consortium, Partner Site, Freiburg, Germany; Department of Urology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Gratzke C; German Cancer Consortium, Partner Site, Freiburg, Germany; Department of Urology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Adebahr S; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium, Partner Site, Freiburg, Germany.
  • Schmidtmayer-Zamboglou B; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Mix M; German Cancer Consortium, Partner Site, Freiburg, Germany; Department of Nuclear Medicine, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Bamberg F; German Cancer Consortium, Partner Site, Freiburg, Germany; Department of Radiology, Faculty of Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
  • Zschaeck S; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin; German Cancer Consortium, Partner Site, Berlin, Germany.
  • Ghadjar P; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin; German Cancer Consortium, Partner Site, Berlin, Germany.
  • Baltas D; German Cancer Consortium, Partner Site, Freiburg, Germany; Division of Medical Physics, Department of Radiation Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Grosu AL; Department of Radiation Oncology, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Germany; German Cancer Consortium, Partner Site, Freiburg, Germany.
Int J Radiat Oncol Biol Phys ; 113(5): 1025-1035, 2022 08 01.
Article en En | MEDLINE | ID: mdl-35469897
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Calidad de Vida Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Calidad de Vida Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans / Male Idioma: En Revista: Int J Radiat Oncol Biol Phys Año: 2022 Tipo del documento: Article